TTEC compared with ATYR: revenue, margins and what each company keeps, and the suppliers and customers both name

TTECTTEC Holdings, Inc.

Mkt capRevenueRevenue

ATYRaTYR PHARMA Inc

Mkt capRevenueRevenue

Compare

TTECTTEC Holdings, Inc.

ATYRaTYR PHARMA Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TTECTTEC Holdings, Inc.

1.59▲+1.52%· post 1.59

Mkt cap$78.4MRevenue$455MQ2 FY26Revenue$2.1BFY25

ATYRaTYR PHARMA Inc

4.72▼−12.08%· post 4.72

ClosedOct 30 '26

Mkt cap$12.1MRevenue$235,000Q1 FY24Revenue—

Compare

ClosedOct 30 '26

TTECTTEC Holdings, Inc.

ATYRaTYR PHARMA Inc

1.59▲+1.52%post 1.59

Price

4.72▼−12.08%post 4.72

$78.4M

Mkt cap

$12.1M

Q2 FY26$455M

Revenue

$235,000Q1 FY24

FY25$2.1B

Revenue

—

TTEC1.59▲+1.52%vsATYR4.72▼−12.08%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

TTEC, solidATYR, dashed

Supply-chain overlap

Revenue flow

TTEC: latest quarter is a loss; flow not drawable. ATYR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: TTEC, ATYR.

Role chip = supplier or customerSource: SEC EDGAR